Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Lupus / August 2008

Tip: Looking for answers? Try searching our database.

Fresh Meat

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
ironjustice - 19 Aug 2008 01:11 GMT
This shows the improvement of the antioxidants in the fish with the
feeding of vegetable oil.
Lack of antioxidants and / or the ability to quench free radicals /
oxidation seems to be a problem in many different disease states.

"oxidative stress"
--------------------

Improvement in Storage Stability of Fish Fillet Using Dietary Soybean
Phospholipids
Food Science and Technology Research
Vol. 14 (2008) , No. 1 pp.55-61

Yoshihiro MURANO1), Tomoko FUNABASHI1), Seiji SEKINE1) and Hiroyuki
TAKEUCHI1)

1) Central Research Laboratory of The Nisshin OilliO Group, Ltd.

(Received: August 2, 2007)
(Accepted: October 7, 2007)

Soybean phospholipids are known to exhibit antioxidant effects on oils
and fats.
However, few studies have examined their antioxidant effects in vivo.
In this study, we investigated the influence of dietary soybean
phospholipids on fish fillet oxidation.
For 4 weeks, we fed rainbow trout diets containing 0, 1.0, or 2.5%
soybean phospholipids, of which the lipid content was adjusted with
soybean oil.
We compared oxidation stability in fillets after the feeding period.
In the fillet of fish fed the soybean phospholipidcontaining diets,
the thiobarbituric acid reactive substance (TBARS) level following an
oxidation test was significantly inhibited compared to that in the
fillet of fish fed a soybean oil-containing diet.
Similarly, the syntheses of malondialdehyde (MDA) and 4-
hydroxyalkenals (HAE) were significantly inhibited.
These results suggest that the administration of soybean phospholipids
improves the storage stability of fish fillet.

Keywords: soybean phospholipids, oxidation, lipid, fish

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/634q5a

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
ironjustice - 19 Aug 2008 02:09 GMT
Protective effects of soybean phospholipid liposome on glutamate-
induced nerve cell injury in vitro★

Jianying Xiao, Xin Zhang, Yujie Liu

Department of Biochemistry, Liaoning Medical University, Jinzhou
121001, Liaoning Province, China

Jianying Xiao★, Master, Professor, Department of Biochemistry,
Liaoning Medical University, Jinzhou    121001, Liaoning Province,
China

Xiao JY, Zhang X, Liu YJ. Protective effects of soybean phospholipid
liposome on glutamate-induced nerve cell injury in vitro. Neural Regen
Res 2007;2(10):587-90

www.sjzsyj.com/Journal/0710/07-10-587.html

Received: 2007-06-27;Accepted: 2007-07-26    (07-S-6-0586/YWY)
Corresponding author: Jianying Xiao, Master, Professor, Department of
Biochemistry, Liaoning Medical University, Jinzhou   121001, Liaoning
Province, China   E-mail: xiaojianying6886@yahoo.com.cn

Abstract
BACKGROUND: It has been previously reported that soybean phosphatide
could reduce the cerebral ischemia damage obviously. Whether soybean
phospholipid liposome (SPL) can protect cerebral cortical neurons
cultured in vitro from glutamate (Glu)-induced neurotoxicity,
particularly nerve cell membrane damage has not been fully
investigated.
OBJECTIVE: To study the protective effects of SPL on Glu-induced
neurotoxicity of neurons in culture, and to discuss the possible
mechanisms of neuroprotection.
DESIGN: Randomized controlled trial.
SETTING: Department of Biochemistry, Liaoning Medical University.
MATERIALS: Twelve Sprague-Dawley rats, of either gender, aged 0 to 1
day, were involved in this study. Drugs and reagents: poly-L-lysine
and L-glutamate were purchased from Sigma company (USA).
METHODS: The study was carried out in the Department of Biochemistry
of Jinzhou Medical University from November 2004 to June 2005.
Glu(1×10-4 mol/L)was added to cortical neurons in injury group for 3
hours, while different concentrations of SPL (0.2, 0.4, 0.8, 1.6 g/L)
were added at the same time in the SPL groups. Neurons in the normal
control group were untouched.
MAIN OUTCOME MEASURES:  According to the instruction of reagent kit,
lactate dehydrogenase(LDH) activity and nitric oxide(NO) content in
the supernatant fluid of the culture medium were assayed, and the
activity of nitric oxide synthase (NOS) and superoxide dismutase(SOD),
malonaldehyde (MDA) content in the neurocytes were also determined.
RESULTS: ①Activities of LDH and NOS,  as well as NO content in the
supernatant fluid of injury group were significantly higher than those
of normal control group (P < 0.01). Activities of LDH and NOS, and NO
content in the supernatant fluid of SPL groups were significantly
lower than those of injury group (P < 0.01). ②MDA content of the SPL
groups was significantly lower than that of injury group (P < 0.01);
SOD activity of neurons in the injury group was significantly lower
than that in the normal control group (P < 0.01), but was
significantly higher than that in the injury group (P < 0.01). ③ The
protective effect of SPL increased with increasing concentration (0.2-
0.8 g/L), and plateaus at around 1.6 g/L.
CONCLUSION: SPL can protect rat cerebral cortical neurons from Glu-
induced neurotoxicity in a dose-dependent manner. This protection is
possibly related to SPL's effect against damages associated with lipid
peroxidation.
Key Words: soybean phospholipid liposome; glutamate; nerve cell
culture; cerebral ischemia

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/634q5a

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
ironjustice - 19 Aug 2008 02:56 GMT
"Lipostabil patients increased their working capacity"
"Lipostabil is phosphatidylcholine a liquid form of lecithin"

http://tinyurl.com/6ny59a

Essential phospholipids versus nicotinic acid in the treatment of
patients with type IIb hyperlipoproteinemia and ischemic heart disease
Auteur(s) / Author(s)
KLIMOV A. N. (1) ; KONSTANTINOV V. O. (1) ; LIPOVETSKY B. M. (1) ;
KUZNETSOV A. S. (1) ; LOZOVSKY V. T. (1) ; TRUFANOV V. F. (1) ;
PLAVINSKY S. L. (1) ; GUNDERMANN K.-J. ; SCHUMACHER R. ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Institute of Experimental Medicine, St. Petersburg, RUSSIE,
FEDERATION DE

Résumé / Abstract
In patients with moderate, dietary noncorrigible hyperlipoproteinemia
type IIb and ischemic heart disease, treatment with nicotinic acid is
limited by the side effects of the drug.
In 100 patients, 6-month treatment with nicotinic acid (n = 50) or
essential phospholipids (EPL) ; Lipostabil®, manufacturer : Rhône-
Poulenc Rorer) (n = 50) indicated comparable efficacy for both
substances : Significant (p <.001) reductions of serum total
cholesterol, low-density lipoprotein (LDL) cholesterol, and
triglyceride values were similar in both groups, while nicotinic acid
increased high-density lipoprotein (HDL) cholesterol significantly (p
<.01) better than Lipostabil.
A detailed analysis of ultracentrifugal lipoprotein profiles,
hydroperoxide concentrations in LDL, and cholesterol-accepting
properties of HDL in a small number of Lipostabil- and nicotinic acid-
treated patients revealed favorable shifts in the lipoprotein profile,
significant (p <.05) reductions of LDL hydroperoxides, and favorable
increases of the most antiatherogenic HDL2b subfraction only in the
Lipostabil-treated group.
Clinically, both medications reduced the intensity and number of
angina pectoris attacks per week (p <.05), but only Lipostabil-treated
patients significantly (p <.05) increased their working capacity in
the veloergometric test.
Since in the nicotinic acid-treated group dropouts (nine patients,
eight related to the drug) and side effects [14] exceeded those in the
Lipostabil-treated group (two dropouts not related to the drug, no
side effects), it is suggested that Lipostabil is a preferable
alternative in the treatment of patients with moderate, dietary
noncorrigible hyperlipoproteinemia IIb and ischemic heart disease.
Revue / Journal Title
Cardiovascular drugs and therapy   ISSN 0920-3206   CODEN CDTHET
Source / Source
1995, vol. 9, no6, pp. 779-784 (9 ref.)
Langue / Language

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/634q5a

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2009 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.